Additionally, histological sections of the lung tissues clearly illustrated the suppressive effect of the treated group on metastatic cancer generation (Fig. 6D, normal group: Fig. S4), suggesting that HO2 inhibitor holds promise as a potential therapeutic drug for metastasis, particularly in lung cancer (Fig. 6E). This evidence concerns the gene HMOX2 and lung cancer.